Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Understanding Vertically Integrated Providers in the Life Settlement Market

    Secondary Life Markets April 10, 2024By Bill Corry
    Share
    Twitter LinkedIn Email

    In the 43 states of the US that have a regulatory infrastructure for the life settlement secondary market, a life settlement provider is involved in every transaction. 

    The reason is because one of the two model acts – the NAIC’s Viatical Settlements Model Act and the NCOIL’s Life Settlements Model Act – used by states that regulate the space require their presence. Whether the life insurance policy is sourced via the direct-to-consumer channel, or the intermediated channel, the provider is an ever-present market participant. 

    The role played by providers in our industry benefits both the asset manager and the consumer – and ultimately, the investor allocating capital to the manager.  

    On the asset manager side, providers are the buyer on record of the life settlement policy, working hard to source these policies for their client(s) either through the direct-to-consumer channel, or through intermediated channels, which often includes life settlement brokers (another licensed entity in both model acts, with a fiduciary duty to the policyholder).  

    On the consumer protection side, providers are licensed entities that are required to furnish policyholders and insureds with certain disclosure forms and documents as part of their process in buying a policy. This requirement is a strength of our industry because it provides important information to policyholders in order for them to make an informed decision as well as the reassurance benefit that the insured is selling to an established, licensed, regulated company. 

    Because providers are involved in every transaction, over time, significant information accrues to them. One example is that life settlement providers have more information about a policyholder’s health and situation than what’s typically available to an asset manager. Similarly, they can aggregate that information to understand policies on a macro level. This helps providers better advise their asset manager clients with regards to the life expectancy of the insured; it provides a second opinion to the external life expectancy underwriting firms that are used commonly in our space. 

    But the buying process can still be cumbersome. Constant back and forth between policyholders to brokers to providers to asset managers makes for a slow process and has been known to put off both buyers and sellers, leading to a less efficient market, and sunk transaction costs. These costs – both time and money costs – ultimately impact the pension fund, foundation, endowment or insurance company that allocates capital to the asset managers. 

    That’s why it may make sense for investors in the space to align with a manager that owns a provider.  

    As I mentioned previously, the information that providers obtain during the course of doing business can become a competitive advantage. But other significant benefits accrue to the asset manager – and, in turn, their clients – that owns a life settlement provider. 

    Deal Flow and Acquisition Costs 

    Providers can work for multiple asset managers during the bidding process for a policy that comes to market through the broker channel, and this can represent a conflict of interest. Owning a provider – and having that provider work with an asset manager – gives the asset manager direct access to the deal flow generated by the provider, potentially at a lower acquisition cost than relying on external brokers. Additionally, it enables the asset manager to source policies direct from the consumer, another route to market that will enable an asset manager to source policies at lower prices originally than those that come through the broker channel. 

    Selection and Quality Control:  

    Asset managers rely on the quality of the policies they buy. Owning a provider allows for more control over the selection process and underwriting standards, potentially leading to a higher quality portfolio. 

    Streamlined Operations:  

    There can be efficiencies gained from integrating the acquisition and asset management functions. This could lead to faster deal processing and potentially lower overall costs. 

    Reputation and Branding:  

    Owning a life settlement provider allows the asset manager to build their reputation and brand within the industry, potentially giving them an edge in attracting new investment capital.   

    Owning a provider brings complexity, however. You either need to launch one – which requires you to play the role of venture capitalist, hiring people, going through the licensing process (in multiple states) and building a brand. Or you play the role of private equity or corporate buyer, acquiring an existing provider, which comes with a higher price.  

    Both of these options require an asset manager to have size and scale, long standing relationships and the ability to access the capital markets competitively. Not only that, but the asset manager needs legal resources to ensure it can navigate the complexities of life settlement provider regulation, which are not insignificant.  

    But for limited partners that are either currently invested in the space, or those that aren’t but are considering it, hiring an asset manager that has the infrastructure to vertically integrate a provider means that the above benefits also filter up to them. Lower acquisition costs means, other things being equal, higher returns. An increased pool of policies to pick from and better quality control means better policies in the portfolio, leading to higher returns. Information asymmetry leads to better policies being acquired, which leads to higher returns. And streamlined operations saves time and money, leading to higher returns. 

    The life settlement industry has evolved significantly over the past twenty years, becoming a genuine consideration for investors that are looking for a non-correlated asset class that can deliver acceptable, risk-adjusted returns. Partnering with an asset manager that has more control over the number and type of policies they are able to buy, via a vertically integrated provider, means more of those non-correlated, risk-adjusted returns. 

    Bill Corry is Managing Partner at Corry Capital Advisors 


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2024 - April Commentary Life Settlements Longevity Risk Volume 3 Issue 4 - April 2024
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.